Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

JAX and BIDMC Announce Multi-faceted Affiliation
Tuesday, September 23, 2014
Collaboration will encompass a broad range of activities to advance cancer research and patient care.

Gene Expression Patterns in Pancreatic CTCs Revealed
Tuesday, September 23, 2014
Distinct patterns of gene expression in several groups of CTCs were identified, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.

EKF Molecular and Massachusetts General Hospital Collaborate
Tuesday, September 23, 2014
Research collaboration to confirm clinical utility of PointMan™ and CTC-iChip technologies for non-invasive cancer diagnosis and monitoring.

Promise for Treatment of Pancreatic Cancer
Monday, September 22, 2014
Ultrasound microbubbles can improve tumor absorption of cancer drugs.

BioLineRx Presents Positive Preclinical Results in Treatment for AML Patients
Saturday, September 20, 2014
Results in this additional indication for BL-8040 presented at Society of Hematologic Oncology Annual Meeting.

Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Friday, September 19, 2014
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.

What Lies Behind the Death of Stem Cells
Friday, September 19, 2014
Researchers have identified key processes that control stem cell survival, providing insights that could improve their use in medicine.

Inventia and Curie-Cancer Epigenetics Partnership
Thursday, September 18, 2014
Led by the Institut Curie and Inventiva, the multi-million euro Epicure project has just been selected for funding by France’s national research agency.

Ovarian Cancer Collaboration with the Medical University of Vienna
Wednesday, September 17, 2014
Collaboration agreement to investigate the clinical use of the Parsortix system for ovarian cancer.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 3208
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv